Clinical investigators may contribute little of essence to drug trials or guidelines, John Ioannidis

Posted by .(JavaScript must be enabled to view this email address)
Wednesday, December 14, 2016 9:05 am Email this article

“Clinical investigators flock to try to get coauthorship in multicenter trials, meta-analyses, and powerful guidelines to which they contribute little of essence,” notes John Ioannidis from Stanford University.

Ioannidis continues by saying,

“Vested interests dictate preemptively large segments of the research agenda and its evidence-based aura which is further propagated in professional societies and large conferences.

“Many leaders and members of powerful professional societies and academies and other august bodies grow out of this system.

“It is sometimes difficult to tell whether a superb CV with a lengthy publication list reflects hard work and brilliant leadership or the composite product of dexterous power game networking, gift authorship, and excellence in the slave trade of younger researchers.”

Reference

Ioannidis JP. Evidence-based medicine has been hijacked: a report to David Sackett. J Clin Epidemiol, 2016 Mar 2; http://www.jclinepi.com/article/S0895-4356(16)00147-5/fulltext.

Author’s Contact Info

John Ioannidis
Department of Medicine
Department of Statistics
Stanford University
1265 Welch Rd, MSOB X306
Stanford, CA 94305, USA
Tel.: 650-7236147
.(JavaScript must be enabled to view this email address)

Articles on the same subject can be found here:

• Just for Fun